Cargando…
A possible new pathway in natural killer cell activation also reveals the difficulty in determining human NK cell function in cancer
Immunotherapy is rapidly becoming the fourth arm of cancer treatment, and breakthrough successes have been observed in multiple malignancies. However, despite the potential for impressive anti-tumor effects, on average, only 25% of patients respond, and barriers clearly remain. Hence, uncovering inn...
Autores principales: | Canter, Robert J., Murphy, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081859/ https://www.ncbi.nlm.nih.gov/pubmed/30086799 http://dx.doi.org/10.1186/s40425-018-0392-0 |
Ejemplares similares
-
Natural killer cell immunotherapy to target stem-like tumor cells
por: Grossenbacher, Steven K., et al.
Publicado: (2016) -
Turning on Natural Killer Cells
por: Lanier, Lewis L.
Publicado: (2000) -
Chewing the fat on natural killer T cell development
por: Godfrey, Dale I., et al.
Publicado: (2006) -
Enhanced natural killer cell targeting of cancer stem cells using Cetuximab
por: Grossenbacher, Steven K, et al.
Publicado: (2014) -
Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity
por: Grossenbacher, Steven, et al.
Publicado: (2015)